ONTOLOGY REPORT - ANNOTATIONS
| Term: | 3-isobutyl-1-methyl-7H-xanthine |
|
| Accession: | CHEBI:34795
|
browse the term
|
| Definition: | A 3-isobutyl-1-methylxanthine that has formula C10H14N4O2. |
| Synonyms: | exact_synonym: | 1-methyl-3-(2-methylpropyl)-3,7-dihydro-1H-purine-2,6-dione |
| | related_synonym: | 1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione; 1-methyl-3-isobutylxanthine; 3-Isobutyl-1-methyxanthine; 3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione; 3-isobutyl-1-methylxanthine; C10H14N4O2; CC(C)Cn1c2nc[nH]c2c(=O)n(C)c1=O; IBMX; InChI=1S/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12); InChIKey=APIXJSLKIYYUKG-UHFFFAOYSA-N |
| | xref_casrn: | 28822-58-4 |
| | xref: | Beilstein:247859 "Beilstein Registry Number"; ChEMBL:108738 "ChEMBL COMPOUND"; ChemIDplus:28822-58-4 "CAS Registry Number"; KEGG COMPOUND:C13708 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D015056 |
| | cyclic_relationship: | is_tautomer_of CHEBI:43253 |
|
|
3-isobutyl-1-methyl-7H-xanthine
|
| G |
100039796 |
predicted gene, 100039796 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions |
EXP |
4 |
53,043,661 |
53,172,767 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
|
increases phosphorylation |
EXP |
11 |
84,008,940 |
84,215,153 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
EXP |
8 |
47,556,396 |
47,621,404 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
EXP |
X |
138,752,536 |
138,825,078 |
RGD:6480464 |
CTD |
| G |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
EXP |
19 |
34,315,581 |
34,329,826 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
EXP |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
multiple interactions |
EXP |
2 |
113,873,025 |
113,878,547 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
EXP |
6 |
83,462,903 |
83,486,245 |
RGD:6480464 |
CTD |
| G |
Adam12 |
a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
|
multiple interactions |
EXP |
7 |
141,074,882 |
141,416,780 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
16 |
85,794,072 |
85,803,360 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
EXP |
17 |
93,598,762 |
93,604,831 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
EXP |
7 |
117,771,183 |
117,773,333 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenergic receptor, alpha 1a |
|
multiple interactions |
ISO |
14 |
67,254,095 |
67,352,166 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenergic receptor, beta 1 |
|
multiple interactions |
ISO |
19 |
56,796,862 |
56,799,352 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
multiple interactions |
EXP |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
multiple interactions |
ISO |
18 |
62,337,470 |
62,339,613 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 (Xenopus laevis) |
|
multiple interactions |
ISO |
12 |
36,719,512 |
36,730,668 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
EXP |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
|
multiple interactions |
EXP |
10 |
5,987,070 |
6,080,212 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
multiple interactions |
ISO |
10 |
24,888,896 |
25,018,969 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
multiple interactions |
ISO |
15 |
42,256,269 |
42,508,341 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
EXP |
17 |
33,911,845 |
33,918,520 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
EXP |
5 |
97,222,404 |
97,274,987 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
multiple interactions |
EXP |
11 |
54,792,464 |
54,846,973 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
multiple interactions |
ISO |
14 |
34,899,176 |
34,913,757 |
RGD:6480464 |
CTD |
| G |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
|
multiple interactions |
EXP |
18 |
63,081,981 |
63,112,849 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
multiple interactions |
EXP |
12 |
53,617,064 |
53,668,839 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
EXP |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
ISO |
11 |
94,269,705 |
94,335,512 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
multiple interactions |
ISO |
17 |
25,511,232 |
25,570,728 |
RGD:6480464 |
CTD |
| G |
Cacna1i |
calcium channel, voltage-dependent, alpha 1I subunit |
|
multiple interactions |
ISO |
15 |
80,117,668 |
80,228,722 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
5 |
15,440,509 |
15,880,329 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
multiple interactions |
EXP |
9 |
62,705,911 |
62,723,725 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
EXP |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
multiple interactions |
EXP |
8 |
97,334,353 |
97,335,936 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
EXP |
11 |
81,859,214 |
81,861,027 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
multiple interactions |
EXP |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
EXP |
8 |
120,807,655 |
121,847,348 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase 1, cytosolic |
|
multiple interactions |
EXP |
18 |
46,872,859 |
46,887,996 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
EXP |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
EXP |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
multiple interactions |
EXP |
2 |
6,460,740 |
7,317,825 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
EXP |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
EXP |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
EXP |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
6 |
18,120,687 |
18,272,770 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha subunit |
|
multiple interactions |
ISO |
4 |
34,841,028 |
34,854,623 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
multiple interactions |
ISO |
6 |
113,374,630 |
113,385,749 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
multiple interactions |
EXP |
6 |
113,374,630 |
113,385,749 |
RGD:6480464 |
CTD |
| G |
Clec3b |
C-type lectin domain family 3, member b |
|
multiple interactions |
EXP |
9 |
123,060,064 |
123,066,550 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
multiple interactions |
ISO |
2 |
25,312,363 |
25,314,292 |
RGD:6480464 |
CTD |
| G |
Cnn2 |
calponin 2 |
|
multiple interactions |
EXP |
10 |
79,451,345 |
79,458,145 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
EXP |
3 |
113,733,458 |
113,923,244 |
RGD:6480464 |
CTD |
| G |
Col15a1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
ISO |
4 |
47,220,884 |
47,326,037 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
EXP |
8 |
11,198,423 |
11,312,826 |
RGD:6480464 |
CTD |
| G |
Col4a6 |
collagen, type IV, alpha 6 |
|
multiple interactions |
ISO |
X |
137,599,946 |
137,908,619 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
EXP |
1 |
92,663,435 |
92,740,514 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
multiple interactions |
ISO |
9 |
108,855,790 |
108,886,920 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin |
|
multiple interactions |
EXP |
3 |
19,857,054 |
19,907,609 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
EXP |
16 |
17,452,080 |
17,486,348 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
3 |
107,543,966 |
107,563,387 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
multiple interactions |
ISO |
19 |
5,344,705 |
5,349,574 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
EXP |
8 |
97,296,080 |
97,306,327 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
multiple interactions |
EXP |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
6 |
117,118,553 |
117,131,386 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
EXP |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
9 |
57,524,744 |
57,531,462 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
multiple interactions |
EXP |
10 |
96,942,134 |
96,980,796 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
EXP |
15 |
76,332,445 |
76,342,248 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
EXP |
12 |
45,306,884 |
45,311,055 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL family member 6, elongation of long chain fatty acids (yeast) |
|
multiple interactions |
EXP |
3 |
129,235,304 |
129,341,413 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
multiple interactions |
EXP |
13 |
118,009,380 |
118,063,222 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
EXP |
6 |
135,312,949 |
135,333,191 |
RGD:6480464 |
CTD |
| G |
Emp2 |
epithelial membrane protein 2 |
|
multiple interactions |
ISO |
16 |
10,281,842 |
10,314,061 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
multiple interactions |
EXP |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
EXP |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
EXP |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fbn2 |
fibrillin 2 |
|
multiple interactions |
EXP |
18 |
58,168,277 |
58,369,580 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthetase |
|
multiple interactions |
EXP |
3 |
88,897,510 |
88,905,867 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
EXP |
9 |
51,751,412 |
51,771,638 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
EXP |
2 |
125,860,394 |
125,916,921 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
EXP |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
multiple interactions |
EXP |
X |
160,811,480 |
160,840,579 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
EXP |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
multiple interactions |
ISO |
17 |
35,960,302 |
35,969,732 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
EXP |
1 |
164,883,931 |
164,914,622 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
multiple interactions |
EXP |
5 |
143,722,034 |
143,734,868 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone beta |
|
multiple interactions |
ISO |
2 |
106,896,297 |
106,899,808 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled homolog 2 (Drosophila) |
|
multiple interactions |
EXP |
11 |
102,465,745 |
102,469,372 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
|
multiple interactions |
EXP |
13 |
51,942,044 |
51,943,844 |
RGD:6480464 |
CTD |
| G |
Galk1 |
galactokinase 1 |
|
multiple interactions |
EXP |
11 |
115,869,671 |
115,874,033 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest specific 2 |
|
multiple interactions |
EXP |
7 |
59,134,515 |
59,249,828 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
EXP |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
increases secretion |
ISO |
11 |
100,195,726 |
100,198,310 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
increases secretion |
ISO |
2 |
62,312,587 |
62,321,710 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
ISO |
2 |
62,312,587 |
62,321,710 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
9 |
77,602,617 |
77,641,458 |
RGD:6480464 |
CTD |
| G |
Glns-ps1 |
glutamine synthetase pseudogene 1 |
|
multiple interactions |
EXP |
11 |
19,620,135 |
19,622,026 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
multiple interactions |
EXP |
9 |
107,516,469 |
107,537,673 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
multiple interactions |
EXP |
19 |
55,144,224 |
55,173,937 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
multiple interactions |
EXP |
1 |
94,728,263 |
94,756,773 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
multiple interactions |
EXP |
15 |
99,548,024 |
99,555,439 |
RGD:6480464 |
CTD |
| G |
Gpr116 |
G protein-coupled receptor 116 |
|
multiple interactions |
ISO |
17 |
43,526,415 |
43,596,506 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
multiple interactions |
EXP |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
multiple interactions |
EXP |
10 |
75,246,558 |
75,261,329 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions |
EXP |
3 |
81,835,926 |
81,878,633 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
multiple interactions |
EXP |
6 |
82,675,019 |
82,724,448 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
multiple interactions |
EXP |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
EXP |
16 |
4,726,361 |
4,766,249 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
multiple interactions |
EXP |
8 |
112,099,028 |
112,103,072 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H1 |
|
multiple interactions |
ISO |
6 |
114,347,930 |
114,433,290 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
multiple interactions |
ISO |
1 |
195,047,834 |
195,090,239 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
multiple interactions |
EXP |
1 |
65,205,190 |
65,233,053 |
RGD:6480464 |
CTD |
| G |
Ifi202b |
interferon activated gene 202B |
|
multiple interactions |
EXP |
1 |
175,892,700 |
175,912,975 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
multiple interactions |
EXP |
1 |
175,677,424 |
175,697,050 |
RGD:6480464 |
CTD |
| G |
Ifi47 |
interferon gamma inducible protein 47 |
|
multiple interactions |
EXP |
11 |
48,900,557 |
48,910,473 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
multiple interactions |
EXP |
19 |
34,715,379 |
34,724,499 |
RGD:6480464 |
CTD |
| G |
Ifnar2 |
interferon (alpha and beta) receptor 2 |
|
multiple interactions |
EXP |
16 |
91,373,028 |
91,405,832 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
EXP |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
EXP |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
EXP |
1 |
72,904,639 |
72,921,439 |
RGD:6480464 |
CTD |
| G |
Iigp1 |
interferon inducible GTPase 1 |
|
multiple interactions |
EXP |
18 |
60,535,683 |
60,552,288 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
multiple interactions |
EXP |
16 |
91,406,480 |
91,426,079 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
multiple interactions |
EXP |
1 |
40,496,494 |
40,522,260 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
EXP |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha chain |
|
decreases expression |
ISO |
2 |
11,564,419 |
11,614,821 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
11 |
53,534,296 |
53,538,605 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
multiple interactions |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
EXP |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
EXP |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin II |
|
multiple interactions |
ISO |
7 |
149,864,561 |
149,865,613 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
multiple interactions |
EXP |
1 |
82,229,680 |
82,288,014 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
EXP |
8 |
10,986,961 |
11,008,430 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
ISO |
5 |
23,825,407 |
23,857,422 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
multiple interactions |
ISO |
14 |
103,375,798 |
103,381,854 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
multiple interactions |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
EXP |
4 |
55,540,009 |
55,545,347 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
multiple interactions |
EXP |
14 |
99,697,910 |
99,712,631 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
multiple interactions |
ISO |
18 |
12,492,533 |
12,741,522 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin B1 |
|
multiple interactions |
EXP |
12 |
31,950,159 |
32,014,504 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
multiple interactions |
ISO |
16 |
19,653,474 |
19,706,458 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
multiple interactions |
EXP |
2 |
158,132,229 |
158,158,588 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
multiple interactions |
EXP |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
multiple interactions |
EXP |
6 |
142,438,769 |
142,456,463 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactose binding, soluble 1 |
|
multiple interactions |
EXP |
15 |
78,757,155 |
78,760,895 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
multiple interactions |
ISO |
11 |
4,157,571 |
4,172,517 |
RGD:6480464 |
CTD |
| G |
Limch1 |
LIM and calponin homology domains 1 |
|
multiple interactions |
ISO |
5 |
67,137,079 |
67,448,398 |
RGD:6480464 |
CTD |
| G |
Lipa |
lysosomal acid lipase A |
|
multiple interactions |
EXP |
19 |
34,566,806 |
34,601,964 |
RGD:6480464 |
CTD |
| G |
Lmo3 |
LIM domain only 3 |
|
multiple interactions |
ISO |
6 |
138,313,002 |
138,530,489 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
multiple interactions |
ISO |
9 |
58,135,530 |
58,161,019 |
RGD:6480464 |
CTD |
| G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
|
multiple interactions |
ISO |
13 |
73,604,831 |
73,651,986 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
multiple interactions |
ISO |
3 |
67,261,921 |
67,267,829 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
multiple interactions |
EXP |
18 |
74,088,140 |
74,224,603 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
EXP |
10 |
36,853,049 |
36,858,732 |
RGD:6480464 |
CTD |
| G |
Mfap5 |
microfibrillar associated protein 5 |
|
multiple interactions |
EXP |
6 |
122,463,694 |
122,479,308 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
multiple interactions |
EXP |
6 |
88,674,406 |
88,778,354 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
EXP |
6 |
138,089,058 |
138,105,273 |
RGD:6480464 |
CTD |
| G |
Mmp16 |
matrix metallopeptidase 16 |
|
multiple interactions |
EXP |
4 |
17,780,629 |
18,045,881 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, transmembrane |
|
multiple interactions |
ISO |
3 |
89,032,974 |
89,037,291 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
EXP |
12 |
33,505,200 |
33,538,234 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
1 |
154,655,020 |
154,684,120 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 |
|
multiple interactions |
EXP |
14 |
20,570,479 |
20,631,009 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
multiple interactions |
ISO |
12 |
57,632,922 |
57,637,895 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
multiple interactions |
EXP |
13 |
49,703,440 |
49,719,869 |
RGD:6480464 |
CTD |
| G |
Omd |
osteomodulin |
|
multiple interactions |
EXP |
13 |
49,678,116 |
49,687,978 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
multiple interactions |
EXP |
4 |
63,005,600 |
63,009,196 |
RGD:6480464 |
CTD |
| G |
Orm2 |
orosomucoid 2 |
|
multiple interactions |
EXP |
4 |
63,023,483 |
63,026,911 |
RGD:6480464 |
CTD |
| G |
Orm3 |
orosomucoid 3 |
|
multiple interactions |
EXP |
4 |
63,017,196 |
63,020,545 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
multiple interactions |
EXP |
5 |
58,109,260 |
58,523,479 |
RGD:6480464 |
CTD |
| G |
Pcx |
pyruvate carboxylase |
|
multiple interactions |
EXP |
19 |
4,510,472 |
4,621,752 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
multiple interactions |
ISO |
2 |
75,829,189 |
76,176,710 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
increases expression |
EXP |
4 |
101,927,347 |
102,279,867 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
multiple interactions |
EXP |
3 |
122,432,076 |
122,562,292 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
increases expression |
EXP |
3 |
122,432,076 |
122,562,292 |
RGD:6480464 |
CTD |
| G |
Pde7a |
phosphodiesterase 7A |
|
multiple interactions |
ISO |
3 |
19,125,918 |
19,211,322 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
10 |
20,117,810 |
20,444,874 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
EXP |
10 |
20,117,810 |
20,444,874 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
10 |
20,117,810 |
20,444,874 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
EXP |
10 |
20,117,810 |
20,444,874 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
61,204,804 |
61,244,721 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
multiple interactions |
EXP |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdlim4 |
PDZ and LIM domain 4 |
|
multiple interactions |
ISO |
11 |
53,868,430 |
53,882,519 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
multiple interactions |
ISO |
11 |
106,515,532 |
106,576,595 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
multiple interactions |
EXP |
11 |
68,912,458 |
68,923,462 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
multiple interactions |
EXP |
4 |
86,302,469 |
86,315,963 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
multiple interactions |
EXP |
13 |
111,185,252 |
111,191,052 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
multiple interactions |
EXP |
2 |
164,665,018 |
164,683,208 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
multiple interactions |
EXP |
1 |
196,446,023 |
196,643,063 |
RGD:6480464 |
CTD |
| G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
|
multiple interactions |
ISO |
8 |
3,515,384 |
3,544,267 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
EXP |
5 |
136,165,084 |
136,211,195 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
|
multiple interactions |
ISO |
17 |
35,642,984 |
35,647,722 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
increases expression |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
ISO |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
multiple interactions |
EXP |
6 |
115,311,239 |
115,440,419 |
RGD:6480464 |
CTD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
EXP |
15 |
5,093,861 |
5,131,899 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
multiple interactions |
EXP |
2 |
167,028,696 |
167,066,037 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase 4a1 |
|
multiple interactions |
EXP |
1 |
30,997,148 |
31,006,600 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
6 |
115,568,591 |
115,626,653 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
EXP |
8 |
13,567,218 |
13,677,587 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
multiple interactions |
ISO |
8 |
3,655,789 |
3,658,096 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
increases expression |
ISO |
8 |
3,655,789 |
3,658,096 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
multiple interactions |
EXP |
1 |
145,846,468 |
145,851,279 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
multiple interactions |
ISO |
4 |
99,768,396 |
100,115,150 |
RGD:6480464 |
CTD |
| G |
Rras |
Harvey rat sarcoma oncogene, subgroup R |
|
multiple interactions |
EXP |
7 |
52,273,377 |
52,277,014 |
RGD:6480464 |
CTD |
| G |
Sc4mol |
sterol-C4-methyl oxidase-like |
|
multiple interactions |
EXP |
8 |
67,196,942 |
67,212,375 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
EXP |
19 |
44,468,940 |
44,482,199 |
RGD:6480464 |
CTD |
| G |
Scg2 |
secretogranin II |
|
decreases activity |
ISO |
1 |
79,431,244 |
79,436,665 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
ISO |
6 |
125,271,358 |
125,294,961 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
multiple interactions |
ISO |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
multiple interactions |
EXP |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
|
increases expression |
EXP |
7 |
129,008,625 |
129,062,030 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
|
multiple interactions |
ISO |
7 |
128,878,021 |
128,911,991 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
multiple interactions |
EXP |
15 |
32,850,478 |
32,964,476 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
multiple interactions |
EXP |
12 |
105,644,918 |
105,652,539 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
multiple interactions |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
multiple interactions |
EXP |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
|
multiple interactions |
EXP |
2 |
84,605,517 |
84,615,586 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
multiple interactions |
EXP |
8 |
24,521,974 |
24,560,104 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
multiple interactions |
EXP |
3 |
83,570,243 |
83,578,236 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant associated protein B |
|
multiple interactions |
ISO |
6 |
72,253,239 |
72,264,364 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant associated protein C |
|
multiple interactions |
ISO |
14 |
70,920,748 |
70,923,888 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
EXP |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12, member 2 |
|
multiple interactions |
EXP |
18 |
58,038,332 |
58,106,475 |
RGD:6480464 |
CTD |
| G |
Slc25a36 |
solute carrier family 25, member 36 |
|
multiple interactions |
ISO |
9 |
96,977,430 |
97,011,460 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
11 |
69,755,788 |
69,761,692 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
|
multiple interactions |
ISO |
3 |
135,488,455 |
135,551,536 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
|
multiple interactions |
EXP |
5 |
89,316,285 |
89,668,681 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
8 |
73,406,788 |
73,416,656 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (neurotransmitter transporter), member 14 |
|
multiple interactions |
ISO |
X |
21,292,026 |
21,319,484 |
RGD:6480464 |
CTD |
| G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
|
multiple interactions |
ISO |
1 |
98,715,361 |
98,768,748 |
RGD:6480464 |
CTD |
| G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
multiple interactions |
EXP |
2 |
164,179,806 |
164,182,243 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
EXP |
5 |
52,755,043 |
52,760,977 |
RGD:6480464 |
CTD |
| G |
Sox2 |
SRY-box containing gene 2 |
|
multiple interactions |
ISO |
3 |
34,548,927 |
34,551,383 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
EXP |
11 |
116,393,225 |
116,397,989 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
multiple interactions |
EXP |
15 |
59,146,647 |
59,162,748 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
multiple interactions |
EXP |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
multiple interactions |
EXP |
9 |
45,737,711 |
45,744,141 |
RGD:6480464 |
CTD |
| G |
Tead4 |
TEA domain family member 4 |
|
multiple interactions |
EXP |
6 |
128,177,161 |
128,250,831 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
1 |
188,447,065 |
188,529,871 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
12 |
87,397,693 |
87,419,991 |
RGD:6480464 |
CTD |
| G |
Thbs2 |
thrombospondin 2 |
|
multiple interactions |
EXP |
17 |
14,802,507 |
14,831,269 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
multiple interactions |
EXP |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
|
multiple interactions |
EXP |
11 |
118,162,375 |
118,216,725 |
RGD:6480464 |
CTD |
| G |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
|
multiple interactions |
EXP |
10 |
85,763,157 |
85,812,250 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like gene family 5 |
|
multiple interactions |
ISO |
7 |
125,740,811 |
125,818,599 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
|
multiple interactions |
ISO |
10 |
18,720,716 |
18,735,216 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
multiple interactions |
EXP |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
multiple interactions |
ISO |
1 |
163,325,569 |
163,348,337 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
multiple interactions |
EXP |
11 |
94,072,768 |
94,076,809 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
multiple interactions |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
multiple interactions |
EXP |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
multiple interactions |
ISO |
3 |
83,965,796 |
84,024,799 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
11 |
73,051,761 |
73,074,009 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
11 |
73,051,761 |
73,074,009 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
multiple interactions |
EXP |
15 |
98,780,278 |
98,783,932 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIA |
|
multiple interactions |
EXP |
13 |
34,166,147 |
34,169,877 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
multiple interactions |
EXP |
8 |
125,935,464 |
125,945,910 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
3 |
115,812,938 |
115,832,606 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
multiple interactions |
EXP |
13 |
89,794,915 |
89,882,117 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
multiple interactions |
ISO |
10 |
120,471,060 |
120,537,698 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
multiple interactions |
EXP |
2 |
163,646,570 |
163,658,882 |
RGD:6480464 |
CTD |
| G |
Wnt5b |
wingless-related MMTV integration site 5B |
|
multiple interactions |
ISO |
6 |
119,382,549 |
119,494,365 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
17 |
74,233,248 |
74,299,522 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
multiple interactions |
EXP |
5 |
33,361,465 |
33,370,615 |
RGD:6480464 |
CTD |
Term paths to the root
|